SCHEMBL20127636

SCHEMBL20127636

c1ccc2cc(-c3ccc4cc(-c5c6ccccc6c(-c6ccc7oc8c(ccc9c%10ccccc%10oc98)c7c6)c6ccccc56)ccc4c3)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALOX5 P09917 2/20 0.40
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
MAPT P10636 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PLA2G2A P14555 2/20 0.37
PLA2G4A P47712 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122442 1.00 CYP1A1 (0.42) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122634 0.99 CYP1A1 (0.41) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122444 0.99 CYP1A1 (0.41) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122391 0.99 CYP1A1 (0.43) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122447 0.97 CYP1A1 (0.40) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122403 0.97 CYP1A1 (0.40) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122405 0.97 CYP1A1 (0.40) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122423 0.96 PLA2G2A (0.41) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122438 0.96 PLA2G2A (0.41) CYP1A1CYP1B1NPC1RAB9ACYP1A2
SCHEMBL10122396 0.96 PLA2G2A (0.41) CYP1A1CYP1B1NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 CYP1A1 399/4885CYP1B1 341/4885NPC1 1202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.